P520 Preferences towards treatment attributes among patients with Crohn’s disease and ulcerative colitis in Argentina, Australia, Brazil, Saudi Arabia and Taiwan: a discrete choice experiment

Marjorie Argollo(Universidade Federal de São Paulo), Elenore Judy B. Uy(Takeda (Singapore)), C J Kuo(Chang Gung Memorial Hospital), Domingo Balderramo(Hospital Privado), Yoon‐Kyo An(Mater Hospital), A. Nahla(King Saud University), Olga Fadeeva(Takeda (Singapore))
Journal of Crohn s and Colitis
January 1, 2024
10.1093/ecco-jcc/jjad212.0650
Cited by 1

Related Papers

Global evolution of inflammatory bowel disease across epidemiologic stages
|Nature|2025|294
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
|Clinical Gastroenterology and Hepatology|2022|271
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
|The Lancet|2024|95
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73